Virginia Retirement Systems Et Al Sage Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 43,000 shares of SAGE stock, worth $241,230. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,000

Previous 41,100 4.62%

Holding current value

$241,230

Previous $1.93 Million 54.24%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$16.75 - $48.98 $31,825 - $93,062	1,900 Added 4.62%	43,000 $884,000
Q2 2023 Aug 22, 2023	BUY	$40.65 - $59.54 $341,460 - $500,136	8,400 Added 25.69%	41,100 $1.93 Million
Q1 2023 Jul 11, 2023	BUY	$37.27 - $46.57 $70,813 - $88,483	1,900 Added 6.17%	32,700 $1.37 Million
Q4 2022 May 17, 2023	BUY	$32.2 - $43.61 $67,620 - $91,581	2,100 Added 7.32%	30,800 $1.17 Billion
Q3 2022 May 16, 2023	SELL	$32.28 - $43.27 $122,664 - $164,426	-3,800 Reduced 11.69%	28,700 $1.12 Billion
Q1 2022 Apr 21, 2022	SELL	$30.71 - $45.71 $104,414 - $155,414	-3,400 Reduced 9.47%	32,500 $1.08 Million
Q4 2021 Feb 03, 2022	SELL	$37.06 - $47.11 $151,946 - $193,151	-4,100 Reduced 10.25%	35,900 $1.53 Million
Q3 2021 Oct 21, 2021	BUY	$40.26 - $57.37 $48,312 - $68,844	1,200 Added 3.09%	40,000 $1.77 Million
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $1.36 Million - $1.97 Million	24,800 Added 177.14%	38,800 $2.2 Million
Q1 2021 Apr 30, 2021	BUY	$70.65 - $96.76 $551,070 - $754,728	7,800 Added 125.81%	14,000 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $134,343 - $204,838	-2,300 Reduced 27.06%	6,200 $536,000
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $82,260 - $124,900	-2,000 Reduced 19.05%	8,500 $520,000
Q2 2020 Aug 12, 2020	BUY	$25.95 - $43.15 $72,660 - $120,820	2,800 Added 36.36%	10,500 $437,000
Q1 2020 May 12, 2020	BUY	$26.15 - $77.24 $7,845 - $23,172	300 Added 4.05%	7,700 $221,000
Q4 2019 Jan 27, 2020	BUY	$60.18 - $154.77 $108,324 - $278,586	1,800 Added 32.14%	7,400 $534,000
Q3 2019 Oct 22, 2019	BUY	$140.29 - $189.96 $224,464 - $303,936	1,600 Added 40.0%	5,600 $786,000
Q2 2019 Jul 26, 2019	SELL	$157.85 - $183.09 $63,140 - $73,236	-400 Reduced 9.09%	4,000 $732,000
Q1 2019 Apr 25, 2019	BUY	$89.33 - $163.65 $151,861 - $278,205	1,700 Added 62.96%	4,400 $700,000
Q4 2018 Feb 07, 2019	BUY	$81.94 - $139.71 $221,238 - $377,217	2,700 New	2,700 $259,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Sage Therapeutics, Inc. Transaction History